NATALIE STUCENSKI: Open Payments
NPI 1144834557 · HOLYOKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 11 payments from 6 companies in 2025. Trend: 2023 $698 · 2024 $509 · 2025 $412
Food & beverage: $312Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $152 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $67 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Grifols USA, LLC | 1 | $26 |
| Philips North America LLC | 1 | $25 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, TRELEGY ELLIPTA, Prolastin-C Liquid, Vest Therapy Und, NUCALA.
Industry payments across MA — which companies pay providers there.
